Table 2.
Relationship of metastasis with age and sex.
| Age in Years, Median (IQR) | Sex, n (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Absent | Present | p | Absent | Present | p | ||||
| Male | Female | Male | Female | ||||||
| ADC | N-MAC | 62 (54–69) | 60 (52–67) | <0.001 | 3995 (54.3) | 3368 (45.7) | 2854 (56.0) | 2238 (44.0) | 0.048 |
| MAC | 63 (55–70) | 60.5 (53–67) | 0.174 | 163 (44.9) | 200 (55.1) | 33 (56.9) | 25 (43.1) | 0.089 | |
| SCC | 66 (60–72) | 65 (58–70) | <0.001 | 4883 (93.7) | 329 (6.3) | 1279 (88.6) | 164 (11.4) | <0.001 | |
| ASC | 64 (57–70) | 58 (52–66) | 0.029 | 63 (77.8) | 18 (22.2) | 29 (64.4) | 16 (35.6) | 0.106 | |
| SGC | 59 (50–66) | 59 (51–67) | 0.908 | 319 (49.6) | 324 (50.4) | 80 (56.3) | 62 (43.7) | 0.147 | |
| SC | 65 (58–72) | 61 (51–69) | 0.001 | 111 (82.2) | 24 (17.8) | 66 (73.3) | 24 (26.7) | 0.111 | |
| NSCLC, NOS | 66 (59–72) | 63 (55–70) | <0.001 | 674 (82.1) | 147 (17.9) | 670 (75.1) | 222 (24.9) | <0.001 | |
| SCLC | 65 (59–71) | 64 (58–70) | 0.036 | 976 (85.2) | 169 (14.8) | 1083 (88.2) | 145 (11.8) | 0.034 | |
| LCNEC | 66 (61–71) | 65 (60–71) | 0.592 | 166 (88.8) | 21 (11.2) | 144 (88.3) | 19 (11.7) | 0.900 | |
| Total | 64 (57–71) | 62 (54–69) | <0.001 | 11,350 (71.2) | 4600 (28.8) | 6238 (68.2) | 2915 (31.8) | <0.001 | |
Bolded text indicates statistical significance at the 0.05 level. IQR, interquartile range; ADC, adenocarcinoma; N-MAC, non-mucinous adenocarcinoma; MAC, mucinous adenocarcinoma; SCC, squamous cell carcinoma; ASC, adenosquamous carcinoma; SGC, salivary-gland type carcinoma; SC, sarcomatoid carcinoma; NSCLC, non-small cell lung cancer; NOS, not otherwise specified; SCLC, small cell lung cancer; LCNEC, large cell neuroendocrine carcinoma.